These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22608274)

  • 21. Digoxin and reduction in mortality in systolic and diastolic heart failure at low serum digoxin concentrations.
    Rahimtoola SH
    Eur Heart J; 2006 Jul; 27(13):1630; author reply 1630-1. PubMed ID: 16760215
    [No Abstract]   [Full Text] [Related]  

  • 22. [The place of cardiac glycosides in the treatment of chronic heart failure. Part II. Results of small studies].
    Sidorenko BA; Preobrazhenskiĭ DV; Sharoshina IA; Bataraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(5):78-85. PubMed ID: 16007062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin: quo vadis?
    Cleland JG; Cullington D
    Circ Heart Fail; 2009 Mar; 2(2):81-5. PubMed ID: 19808321
    [No Abstract]   [Full Text] [Related]  

  • 24. Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
    Gheorghiade M; Gattis WA; Adams KF; Jaffe AS; O'Connor CM; ;
    Am Heart J; 2003 Feb; 145(2 Suppl):S55-7. PubMed ID: 12594453
    [No Abstract]   [Full Text] [Related]  

  • 25. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of digoxin on mortality and morbidity in patients with heart failure.
    Digitalis Investigation Group
    N Engl J Med; 1997 Feb; 336(8):525-33. PubMed ID: 9036306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necessary cautions when considering digoxin in heart failure.
    Heckman GA; McKelvie RS
    CMAJ; 2007 Feb; 176(5):644-5. PubMed ID: 17325330
    [No Abstract]   [Full Text] [Related]  

  • 28. Overview of the DIG trial.
    Collins JF; Egan D; Yusuf S; Garg R; Williford WO; Geller N;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):269S-276S. PubMed ID: 14643073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digoxin: old friend or old foe? The controversial heart failure drug has a new role in limiting hospital stays.
    Harv Heart Lett; 2014 Sep; 25(1):4. PubMed ID: 25291817
    [No Abstract]   [Full Text] [Related]  

  • 30. Appropriate use of digoxin in treating older nursing home patients with heart failure.
    Aronow WS
    J Am Med Dir Assoc; 2006 Nov; 7(9):604-6. PubMed ID: 17095428
    [No Abstract]   [Full Text] [Related]  

  • 31. Digoxin in patients with heart failure.
    Böhm M
    N Engl J Med; 1997 Jul; 337(2):129-30; author reply 130-1. PubMed ID: 9221339
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions.
    Ambrosy AP; Butler J; Ahmed A; Vaduganathan M; van Veldhuisen DJ; Colucci WS; Gheorghiade M
    J Am Coll Cardiol; 2014 May; 63(18):1823-32. PubMed ID: 24613328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of target concentration intervention strategy with conventional dosing of digoxin.
    Rajendran SD; Rao YM; Thanikachalam S; Muralidharan TR; Anbalagan M
    Indian Heart J; 2005; 57(3):265-7. PubMed ID: 16196188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin and heart failure.
    McMurray J
    Lancet; 2000 Jan; 355(9197):69-70. PubMed ID: 10615915
    [No Abstract]   [Full Text] [Related]  

  • 35. [The place of cardiac glycosides in the treatment of chronic heart failure. Part III. The DIG trial].
    Sidorenko BA; Preobrazhenskiĭ DV; Sharoshina IA; Batyraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(6):61-70. PubMed ID: 16007036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversy in heart failure management: Digoxin use in the elderly.
    Chun J; Chodosh J
    J Am Med Dir Assoc; 2006 Nov; 7(9):581-6. PubMed ID: 17095423
    [No Abstract]   [Full Text] [Related]  

  • 37. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA
    Clin Excell Nurse Pract; 2000 Jul; 4(4):197-204. PubMed ID: 11261079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy.
    Adams KF; Gheorghiade M; Uretsky BF; Young JB; Patterson JH; Tomasko L; Packer M
    Am Heart J; 1998 Mar; 135(3):389-97. PubMed ID: 9506323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Digoxin: the results of the DIG study in the XXI century].
    Helber I; Tucci PJ
    Arq Bras Cardiol; 2010 Oct; 95(4):e108-11. PubMed ID: 21180781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is digoxin a drug of the past?
    Pervaiz MH; Dickinson MG; Yamani M
    Cleve Clin J Med; 2006 Sep; 73(9):821-4, 826, 829-32 passim. PubMed ID: 16970134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.